Since combined inhibition of AKT and HSF1 resulted in a synergistic effect in killing breast cancer cells in vitro (Figure 5), we asked whether this treatment strategy can be translated into an in vivo effect. This evidence concerns the gene AKT1 and breast carcinoma.